[父系GNAS突变:哪些表型?如何进行遗传咨询?]
[Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
作者信息
Kottler Marie-Laure
机构信息
Department of Genetics, Reference centre for rare disease of calcium and phosphorus metabolism, Caen University Hospital, 14033 Caen, France.
出版信息
Ann Endocrinol (Paris). 2015 May;76(2):105-9. doi: 10.1016/j.ando.2015.03.010. Epub 2015 May 4.
Parental imprinting and the type of the genetic alteration play a determinant role in the phenotype expression of GNAS locus associated to pseudohypoparathyroidism (PHP). GNAS locus gives rise to several different messenger RNA transcripts that are derived from the paternal allele, the maternal allele, or both and can be either coding or non-coding. As a consequence, GNAS mutations lead to a wide spectrum of phenotypes. An alteration in the coding sequence of the gene leads to a haplo-insufficiency and a dysmorphic phenotype (Albright's syndrome or AHO). AHO is a clinical syndrome defined by specific physical features including short stature, obesity, round-shaped face, subcutaneous ossifications, brachymetarcapy (mainly of the 4th and 5th ray). If the alteration is on the maternal allele, there is a hormonal resistance to the PTH at the kidney level and to the TSH at the thyroid level. The phenotype is known as pseudohypoparathyroidism type 1a (PHP1a). If the alteration is on the paternal allele, there are few clinical signs with no hormonal resistance and the phenotype is known as pseudopseudo hypoparathyroidism (pseudo-PPHP). Heterozygous GNAS mutations on the paternal GNAS allele were associated with intra uterin growth retardation (IUGR). Moreover, birth weights were lower with paternal GNAS mutations affecting exon 2-13 than with exon 1/intron 1 mutations suggesting a role for loss of function XLαs. Progressive osseous heteroplasia (POH) is a rare disease of ectopic bone formation, characterized by cutaneous and subcutaneous ossifications progressing towards deep connective and muscular tissues. POH is caused by a heterozygous GNAS inactivating mutation and has been associated with paternal inheritance. However, genotype/phenotype correlations suggest that there is no direct correlation between the ossifying process and parental origin, as there is high variability in heterotopic ossification. Clinical heterogeneity makes genetic counseling a very delicate matter, specifically where paternal inheritance is concerned as it can lead either to a mild expression of pseudo-PHP or to a severe one of POH.
亲本印记和基因改变的类型在与假性甲状旁腺功能减退症(PHP)相关的GNAS基因座的表型表达中起决定性作用。GNAS基因座产生几种不同的信使核糖核酸转录本,这些转录本来源于父本等位基因、母本等位基因或两者,并且可以是编码的或非编码的。因此,GNAS突变导致广泛的表型。基因编码序列的改变导致单倍体不足和畸形表型(奥尔布赖特综合征或AHO)。AHO是一种临床综合征,由特定的身体特征定义,包括身材矮小、肥胖、圆脸、皮下骨化、短掌骨(主要是第4和第5掌骨)。如果改变发生在母本等位基因上,则在肾脏水平对甲状旁腺激素以及在甲状腺水平对促甲状腺激素存在激素抵抗。这种表型被称为1a型假性甲状旁腺功能减退症(PHP1a)。如果改变发生在父本等位基因上,则几乎没有临床症状且无激素抵抗,这种表型被称为假假性甲状旁腺功能减退症(pseudo-PPHP)。父本GNAS等位基因上的杂合GNAS突变与宫内生长迟缓(IUGR)有关。此外,影响外显子2 - 13的父本GNAS突变导致的出生体重低于外显子1/内含子1突变,这表明功能丧失的XLαs起了作用。进行性骨化性纤维发育不良(POH)是一种罕见的异位骨形成疾病,其特征是皮肤和皮下骨化向深部结缔组织和肌肉组织发展。POH由杂合GNAS失活突变引起,并且与父系遗传有关。然而,基因型/表型相关性表明,骨化过程与亲本来源之间没有直接相关性,因为异位骨化存在高度变异性。临床异质性使得遗传咨询成为一件非常棘手的事情,特别是在涉及父系遗传时,因为它可能导致假性PHP的轻度表达或POH的重度表达。